Stockreport

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for the full year of 2023, its u [Read more]